Table 1.
Demographic, insurance and medical characteristics of MIH patients
All (n = 110) | HF group (n = 45) | LF group (n = 65) | Pd | |||||||
---|---|---|---|---|---|---|---|---|---|---|
N | % | μ | N | % | μ | N | % | μ | ||
Sociodemographic | ||||||||||
Age (years) | ||||||||||
19–33 | 12 | 10.9 | 60.3 | 5 | 11.1 | 58.2 | 7 | 10.8 | 61.8 | 0.538 |
34–48 | 14 | 12.7 | 5 | 11.1 | 9 | 13.8 | ||||
49–64 | 35 | 31.8 | 18 | 40.0 | 17 | 26.2 | ||||
65–78 | 34 | 30.9 | 13 | 28.9 | 21 | 32.3 | ||||
79+ | 15 | 13.6 | 4 | 8.9 | 11 | 16.9 | ||||
Race/ethnicity | ||||||||||
White | 26 | 23.6 | 9 | 20.0 | 17 | 26.2 | 0.613 | |||
Asian | 1 | 0.9 | 1 | 2.2 | 0 | 0.0 | ||||
Blacks | 81 | 73.6 | 34 | 75.6 | 47 | 72.3 | ||||
Hispanic | 2 | 1.8 | 1 | 2.2 | 1 | 1.5 | ||||
Sex | ||||||||||
Male | 56 | 50.9 | 19 | 42.2 | 37 | 56.9 | 0.929 | |||
Female | 54 | 49.1 | 26 | 57.8 | 28 | 43.1 | ||||
Marital status | ||||||||||
Single | 69 | 67.6 | 28 | 66.7 | 41 | 68.3 | 0.873 | |||
Married | 25 | 24.5 | 12 | 28.6 | 13 | 21.7 | ||||
Divorced | 5 | 4.9 | 1 | 2.4 | 4 | 6.7 | ||||
Widowed | 3 | 2.9 | 1 | 2.4 | 2 | 3.3 | ||||
Persons living in residence | 2.2 | 2.2 | 2.2 | 0.236 | ||||||
Means of first contact | ||||||||||
Door knock/cold call | 1 | 0.9 | 1 | 2.3 | 0 | 0.0 | 0.482 | |||
Hospital visit | 5 | 4.5 | 2 | 4.5 | 3 | 4.6 | ||||
Phone call | 104 | 94.5 | 42 | 95.5 | 62 | 95.4 | ||||
Assessments and medications | ||||||||||
Fall risk score (n = 87)a | ||||||||||
Low | 64 | 73.6 | 2.5 | 28 | 71.8 | 2.8 | 36 | 75.0 | 2.4 | 0.645 |
High | 23 | 26.4 | 11 | 28.2 | 12 | 25.0 | ||||
Compliance with medications | ||||||||||
Never | 10 | 9.1 | 6 | 13.3 | 4 | 6.2 | 0.171 | |||
Sometimes | 35 | 31.8 | 17 | 37.8 | 18 | 27.7 | ||||
Always | 65 | 59.1 | 22 | 48.9 | 43 | 66.2 | ||||
Number of medicationsb | ||||||||||
1–3 | 12 | 11.9 | 12.3 | 5 | 11.1 | 12.1 | 7 | 12.1 | 12.5 | 0.973 |
4–6 | 8 | 7.9 | 4 | 9.3 | 4 | 6.9 | ||||
7–9 | 4 | 4.0 | 1 | 2.3 | 3 | 5.2 | ||||
10–12 | 20 | 19.8 | 10 | 23.3 | 10 | 17.2 | ||||
13–15 | 18 | 17.8 | 7 | 16.3 | 11 | 19.0 | ||||
16–18 | 34 | 33.7 | 14 | 32.6 | 20 | 34.5 | ||||
19+ | 5 | 5.0 | 2 | 4.7 | 3 | 5.2 | ||||
Insurance/access | ||||||||||
Has a PCP | ||||||||||
Yes | 102 | 92.7 | 42 | 93.3 | 60 | 92.3 | 0.839 | |||
No | 8 | 7.3 | 3 | 6.7 | 5 | 7.7 | ||||
Has insurance | ||||||||||
Yes | 110 | 100.0 | 45 | 100.0 | 65 | 100.0 | ||||
No | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | ||||
Dual eligible? | ||||||||||
Yes | 18 | 16.4 | 10 | 22.2 | 8 | 12.3 | 0.167 | |||
No | 92 | 83.6 | 35 | 77.8 | 57 | 87.7 | ||||
Primary insurance | ||||||||||
Private | 14 | 12.7 | 4 | 8.9 | 10 | 15.4 | 0.439 | |||
Medicaid | 35 | 31.8 | 17 | 37.8 | 18 | 27.7 | ||||
Medicare | 61 | 55.5 | 24 | 53.3 | 37 | 56.9 | ||||
Travel times to PCP | ||||||||||
0–9 min | 9 | 8.2 | 22.8 | 4 | 8.9 | 22.4 | 5 | 7.7 | 23.1 | 0.989 |
10–19 min | 34 | 30.9 | 15 | 33.3 | 19 | 29.2 | ||||
20–29 min | 41 | 37.3 | 16 | 35.6 | 25 | 38.5 | ||||
30–39 min | 16 | 14.5 | 6 | 13.3 | 10 | 15.4 | ||||
40 min or longer | 10 | 9.1 | 4 | 8.9 | 6 | 9.2 | ||||
Clinical/chronic illness | ||||||||||
Asthma/COPD | ||||||||||
No | 73 | 66.4 | 29 | 64.4 | 44 | 67.7 | 0.723 | |||
Yes | 37 | 33.6 | 16 | 35.6 | 21 | 32.3 | ||||
Hypertension | ||||||||||
No | 35 | 31.8 | 16 | 35.6 | 19 | 29.2 | 0.484 | |||
Yes | 75 | 68.2 | 29 | 64.4 | 46 | 70.8 | ||||
Hypercholesterolemia | ||||||||||
No | 81 | 73.6 | 32 | 71.1 | 49 | 75.4 | 0.617 | |||
Yes | 29 | 26.4 | 13 | 28.9 | 16 | 24.6 | ||||
Chronic heart failure | ||||||||||
No | 84 | 76.4 | 31 | 68.9 | 53 | 81.5 | 0.125 | |||
Yes | 26 | 23.6 | 14 | 31.1 | 12 | 18.5 | ||||
Stroke/CVA | ||||||||||
No | 85 | 77.3 | 35 | 77.8 | 50 | 76.9 | 0.916 | |||
Yes | 25 | 22.7 | 10 | 22.2 | 15 | 23.1 | ||||
Psychiatric/behavioral | ||||||||||
No | 70 | 63.6 | 25 | 55.6 | 45 | 69.2 | 0.143 | |||
Yes | 40 | 36.4 | 20 | 44.4 | 20 | 30.8 | ||||
Diabetes | ||||||||||
No | 64 | 58.2 | 28 | 62.2 | 36 | 55.4 | 0.475 | |||
Yes | 46 | 41.8 | 17 | 37.8 | 29 | 44.6 |
HF High frequency users, LF low frequency users
aIncludes only patients who were considered at risk for falls
bIncludes only patients with reported number of medications
cEight (8) observations with “No response”
dSignificance = .05